SWOG clinical trial number
S0511

A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer"

0% Accrual
Accrual
0%
Closed
Phase
0% Accrual
Accrual
0%
Abbreviated Title
ADVANCED: Male Breast Cancer
Activated
09/15/2005
Closed
01/10/2007
Participants
NCORP, Members, Medical Oncologists

Research committees

Breast Cancer

Treatment

Goserelin Acetate Anastrozole

Other Clinical Trials

CTSU-A012301
SWOG Clinical Trial Number
S2212
SWOG Clinical Trial Number
Research Committee(s)
Breast Cancer
Activated
07/21/2023
31% Accrual
Accrual
31%
Open
Phase